Search research articles
Contact Us
Filters
Showing results (71-80 of 99) with videos related to
Page
of 10
Sort By:
Cancer Research Communications
|
February 5, 2025
A Phase 2 Study of Sotigalimab, a CD40 Agonist Antibody, plus Concurrent Chemoradiation as Neoadjuvant Therapy for Esophageal and Gastroesophageal Junction Cancers
Andrew H Ko, Joseph Chao, Marcus S Noel, et al.
Journal of Gastrointestinal Oncology
|
January 13, 2017
Radioembolization with <sup>90</sup>Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: final report of a prospective pilot study
Nicholas Fidelman, Robert K Kerlan, Randall A Hawkins, et al.
Nature Medicine
|
April 5, 2011
Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
Eric A Collisson, Anguraj Sadanandam, Peter Olson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 8, 2015
A Multicenter, Open-Label Phase II Clinical Trial of Combined MEK plus EGFR Inhibition for Chemotherapy-Refractory Advanced Pancreatic Adenocarcinoma
Andrew H Ko, Tanios Bekaii-Saab, Jessica Van Ziffle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 27, 2009
A phase I study of a 2-day lapatinib chemosensitization pulse preceding nanoparticle albumin-bound Paclitaxel for advanced solid malignancies
Amy J Chien, Julie A Illi, Andrew H Ko, et al.
Physical Biology
|
February 7, 2012
Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers
Dena Marrinucci, Kelly Bethel, Anand Kolatkar, et al.
The Oncologist
|
March 20, 2023
Atezolizumab Plus PEGPH20 Versus Chemotherapy in Advanced Pancreatic Ductal Adenocarcinoma and Gastric Cancer: MORPHEUS Phase Ib/II Umbrella Randomized Study Platform
Andrew H Ko, Kyu-Pyo Kim, Jens T Siveke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2026
Efficacy of the ATR inhibitor ceralasertib in patients with ARID1A-deficient gynecologic and other solid tumor malignancies
Xiaolin Zhu, Edwin A Alvarez, Sarah E Umetsu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 28, 2020
A Phase II Study of Allogeneic GM-CSF-Transfected Pancreatic Tumor Vaccine (GVAX) with Ipilimumab as Maintenance Treatment for Metastatic Pancreatic Cancer
Annie A Wu, Katherine M Bever, Won Jin Ho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 8, 2011
Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology
Nicholas J Vogelzang, Steven I Benowitz, Sylvia Adams, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 99) with videos related to
Sort By:
Page
of 10
Cancer Research Communications
|
February 5, 2025
A Phase 2 Study of Sotigalimab, a CD40 Agonist Antibody, plus Concurrent Chemoradiation as Neoadjuvant Therapy for Esophageal and Gastroesophageal Junction Cancers
Andrew H Ko, Joseph Chao, Marcus S Noel, et al.
Journal of Gastrointestinal Oncology
|
January 13, 2017
Radioembolization with <sup>90</sup>Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: final report of a prospective pilot study
Nicholas Fidelman, Robert K Kerlan, Randall A Hawkins, et al.
Nature Medicine
|
April 5, 2011
Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
Eric A Collisson, Anguraj Sadanandam, Peter Olson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 8, 2015
A Multicenter, Open-Label Phase II Clinical Trial of Combined MEK plus EGFR Inhibition for Chemotherapy-Refractory Advanced Pancreatic Adenocarcinoma
Andrew H Ko, Tanios Bekaii-Saab, Jessica Van Ziffle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 27, 2009
A phase I study of a 2-day lapatinib chemosensitization pulse preceding nanoparticle albumin-bound Paclitaxel for advanced solid malignancies
Amy J Chien, Julie A Illi, Andrew H Ko, et al.
Physical Biology
|
February 7, 2012
Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers
Dena Marrinucci, Kelly Bethel, Anand Kolatkar, et al.
The Oncologist
|
March 20, 2023
Atezolizumab Plus PEGPH20 Versus Chemotherapy in Advanced Pancreatic Ductal Adenocarcinoma and Gastric Cancer: MORPHEUS Phase Ib/II Umbrella Randomized Study Platform
Andrew H Ko, Kyu-Pyo Kim, Jens T Siveke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2026
Efficacy of the ATR inhibitor ceralasertib in patients with ARID1A-deficient gynecologic and other solid tumor malignancies
Xiaolin Zhu, Edwin A Alvarez, Sarah E Umetsu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 28, 2020
A Phase II Study of Allogeneic GM-CSF-Transfected Pancreatic Tumor Vaccine (GVAX) with Ipilimumab as Maintenance Treatment for Metastatic Pancreatic Cancer
Annie A Wu, Katherine M Bever, Won Jin Ho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 8, 2011
Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology
Nicholas J Vogelzang, Steven I Benowitz, Sylvia Adams, et al.
Page
of 10